Back

The role of education level in the mortality of hospitalized patients with atrial fibrillation

16 April 2023 (13:00 - 13:55)
Organised by:
Congress Presentation Part of: ePoster session 7 Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Aron Sztaniszlav

Orebro University Hospital, Orebro (Sweden)

8 More presentations in this session

Presentation thumbnail
Differences in acute outcomes and complications of pulmonary vein isolation using pulsed field ablation with or without 3D mapping system for paroxysmal atrial fibrillation
Doctor A. Fueting (Essen, DE)
Abstract Slides
Presentation thumbnail
Single-center outcome after ablation of atrial fibrillation using very high-power short duration pulmonary vein isolation
Doctor U. Rohrer (Graz, AT)
Abstract Slides
Presentation thumbnail
Novel pulsed-field ablation technology for pulmonary vein isolation in patients with atrial fibrillation: preliminary experience from a large multicenter clinical practice
Doctor S. Iacopino (Cotignola, IT)
Abstract Slides
Presentation thumbnail
Predictors and outcomes of late atrial fibrillation following coronary artery bypass grafting
Doctor F. Masoudkabir (Tehran, IR)
Abstract Slides
Presentation thumbnail
Mid-term follow-up of atrioventricular node ablation and conduction system pacing without a ventricular backup lead in atrial fibrillation-induced tachycardiomyopathy - a single-center experience
Doctor C. Pestrea (Brasov, RO)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 7

The Event

Event poster

EHRA 2023

16 April 2023 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Socioeconomic position, mediators, and risk of atrial fibrillation in a general, adult population
5 April 2025
thumbnail
Congress Presentation
Predictors of 30-day and 1-year mortality after a hospital discharge due to HF in elderly patients in Spain.
22 May 2023
thumbnail
Congress Presentation
Educational level and risk of all-cause death in patients with heart failure with reduced ejection fraction (HFrEF): a report from the WARCEF Trial
26 August 2023
thumbnail
Congress Presentation
Management and impact of atrial fibrillation in the COVID 19 era; concomitancy of two procoagulant phenomena
29 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources